MCL1 and head and neck cancer: Increased phosphorylated STAT3 and Mcl-1 have been often associated with poor prognosis and poor outcome response to chemo- and radiotherapy in various tumors, including head and neck cancer, and inhibition of STAT3 is known to block cancer cell proliferation [7, 9].